In 2019, the addictions therapeutics market was valued at approximately 6,691.01 million USD and is anticipated to grow to around 10,735.94 million USD by 2027, reflecting a compound annual growth rate (CAGR) of 6.2% from 2020 to 2027.
The surge in addiction rates among the general population, coupled with heightened awareness initiatives, are significant contributors to the market's expansion. Additionally, the increasing demand for research and development from contract organizations is expected to further propel market growth throughout the forecast period. However, the high costs associated with drug development pose a challenge to the growth of the addictions therapeutics sector. Furthermore, countries in the Asia-Pacific (APAC) region are grappling with difficulties stemming from the rising incidence of COVID-19. The disruptions in supply chains and the overwhelming need for effective COVID-19 treatments are imposing restrictions on healthcare research activities in this region.
The global addictions therapeutics market is categorized based on treatment type, drug type, treatment center, and distribution channel. In terms of treatment type, the market is divided into nicotine addiction treatment, alcohol addiction treatment, opioid addiction treatment, and treatment for other substance addictions. The nicotine addiction treatment segment dominated the market in 2019 and is projected to experience the highest CAGR during the forecast period. Regarding drug type, the market includes varenicline, bupropion, nicotine replacement products, buprenorphine, naltrexone, disulfiram, and others. The varenicline segment held the largest market share in 2019, while the nicotine replacement products segment is expected to achieve the highest CAGR from 2020 to 2027. When considering treatment centers, the addictions therapeutics market is segmented into outpatient treatment centers, residential treatment centers, and inpatient treatment centers. The outpatient treatment center segment was the largest in 2019 and is forecasted to register the highest CAGR from 2020 to 2027. Lastly, the market is segmented by distribution channel into hospital pharmacies, medical stores, and others. In 2019, hospital pharmacies held the largest market share, but the medical stores segment is projected to experience the highest CAGR during the forecast period.
Key organizations such as the World Health Organization (WHO), the American Addictions Center, and the Centers for Disease Control and Prevention (CDC) are among the primary and secondary sources referenced in the report concerning the addictions therapeutics market.